Blinatumomab in B-ALL: BiTE Construction, Mechanism, Resistance & Trials
Writer: Alisha G CSummaryBlinatumomab is a first-in-class bispecific T-cell engager (BiTE) antibody…
Writer: Alisha G CSummaryBlinatumomab is a first-in-class bispecific T-cell engager (BiTE) antibody…

Sign in to your account
